Close Menu

NEW YORK (GenomeWeb News) – Waters said today that the Chinese Food and Drug Administration has approved registration of its Acquity UPLC TQD system for sale as a medical device for routine diagnostic applications and neonatal metabolites disease screening.

The device is the second of Waters to receive Chinese approval for in vitro diagnostic applications. In 2008, the CFDA approved a neonatal screening test on the company's Quattro micro mass spec.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.